Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.78 | 12.76 |
| PEG Ratio (TTM) | 0.92 | 0.89 |
| P/S Ratio (TTM) | 2.38 | 2.55 |
| P/B Ratio (TTM) | 1.53 | 1.71 |
| P/FCF Ratio (TTM) | 13.79 | 9.91 |
| Price to 5YR AVG Earnings Ratio | 14.25 | 13.66 |
| Price to 5YR AVG FCF Ratio | 10.95 | 7.55 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.14% | 9.40% |
| ROE (TTM) | 13.61% | 9.27% |
| Net Profit Margin (TTM) | 20.17% | 16.06% |
| ROIC 5YR AVG | -34.89% | 19.82% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.44% | 30.40% | 12.80% |
| Revenue | 9.67% | 13.33% | 12.01% |
| Net Income | 15.78% | 25.49% | 8.20% |
| Cash Flow | 13.39% | -1,344.33% | -817.50% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.05 | 2.84 |
| Quick Ratio (TTM) | 0.41 | 4.31 |
| D/E Ratio (TTM) | 0.23 | 1.35 |
| Interest Coverage (TTM) | 1.05 | 0.70 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | N/A | 0.30 |
| LTL to 5YR AVG FCF | 0.68 | 6.38 |
| Shares Outstanding Growth 5YR AVG | -4.01% | 5.13% |